MAPT and in situ carcinoma: No significant correlations were observed between α-synuclein, p-Tau or Aβ pathology in PCC and Pr/Cu with CIS ratios, or 99mTc-HMPAO SPECT uptake in PCC or Pr/Cu within DLB group.